Vineet Laboratories Stock Screener | Share Price & Fundamental Analysis
VINEETLAB
Pharmaceuticals
Share Price NSE
₹30.31
▲
0.39 (1.30%)
Share Price BSE
₹30.21
▲
0.34 (1.14%)
Track Vineet Laboratories share price live with TickJournal's free stock screener.
Analyze Vineet Laboratories share price history trends and compare 52-week high low
levels.
Calculate VINEETLAB stock fair value using fundamental analysis and view live share price charts.
Determine Vineet Laboratories share intrinsic value and compare it with current VINEETLAB share price.
Record your Vineet Laboratories trades in TickJournal's free trading journal and track your portfolio performance.
Vineet Laboratories Market Cap
₹75.17 Cr.
EPS (TTM)
₹-21.90
Dividend Yield
-
Debt to Equity
1.71
VINEETLAB 52 Week High
₹47.87
Vineet Laboratories 52 Week Low
₹29.53
Operating Margin
-20.00%
Profit Margin
-28.81%
VINEETLAB Revenue (TTM)
₹59.00
EBITDA
₹-10.00
Net Income
₹-17.00
Total Assets
₹95.00
Total Equity
₹15.00
Vineet Laboratories Share Price History - Stock Screener Chart
Screen VINEETLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Vineet Laboratories Company Profile - Fundamental Screener
Screen Vineet Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VINEETLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE505Y01010
Vineet Laboratories Balance Sheet Screener
Screen VINEETLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 95 | 117 | 116 | 133 | 109 | 0 | 0 |
| Current Assets | 67 | 88 | 88 | 103 | 86 | 0 | 0 |
| Fixed Assets | 26 | 27 | 27 | 21 | 20 | 0 | 0 |
| Liabilities | |||||||
| Total Liabilities | 95 | 117 | 116 | 133 | 109 | 0 | 0 |
| Current Liabilities | 6 | 6 | 8 | 5 | 8 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 15 | 35 | 34 | 33 | 27 | 0 | 0 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 0 | 0 |
| Reserves & Surplus | 5 | 26 | 25 | 24 | 17 | 0 | 0 |
Vineet Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Vineet Laboratories income statement and profit fundamentals.
Analyze VINEETLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vineet Laboratories share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 59 | 77 | 151 | 212 | 192 | 244 | 0 | 0 |
| Expenses | 69 | 91 | 143 | 205 | 178 | 235 | 0 | 0 |
| EBITDA | -10 | -14 | 8 | 8 | 13 | 9 | 0 | 0 |
| Operating Profit % | -20.00% | -22.00% | 5.00% | 4.00% | 7.00% | 3.00% | 0.00% | 0.00% |
| Depreciation | 3 | 3 | 3 | 2 | 2 | 2 | 0 | 0 |
| Interest | 5 | 4 | 5 | 3 | 2 | 3 | 0 | 0 |
| Profit Before Tax | -17 | -21 | 0 | 2 | 9 | 4 | 0 | 0 |
| Tax | 0 | -1 | -1 | 1 | 3 | 2 | 0 | 0 |
| Net Profit | -17 | -20 | 1 | 1 | 7 | 2 | 0 | 0 |
| EPS | -18.10 | -21.90 | 1.11 | 1.36 | 7.16 | 2.18 | -0.27 | 0.00 |
Vineet Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen VINEETLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 12 | -7 | -10 | 8 | 28 | 0 |
| Investing Activities | -3 | -2 | -7 | -4 | -8 | 0 |
| Financing Activities | -8 | 8 | 0 | 12 | 19 | 0 |
| Net Cash Flow | 0 | 0 | -16 | 16 | 38 | 0 |
Vineet Laboratories Shareholding Pattern Screener
See Vineet Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Vineet Laboratories promoter holding and ownership changes for VINEETLAB on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.85% | 29.26% | 15.89% | 37.50% | 37.50% | 36.07% | 35.85% | 38.66% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 58.67% | 66.95% | 78.16% | 59.07% | 59.10% | 60.65% | 59.33% | 58.63% |
| Other Holding | 5.49% | 3.79% | 5.94% | 3.42% | 3.39% | 3.27% | 4.83% | 2.72% |
| Shareholder Count | 10,025 | 9,988 | 9,682 | 9,638 | 9,523 | 10,300 | 10,058 | 9,821 |
Vineet Laboratories Share Dividend Screener - Share Yield Analysis
Check Vineet Laboratories dividend history with payout and yield data.
View Vineet Laboratories dividend details including ex-dates and amounts for VINEETLAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.00 | 2.86% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Vineet Laboratories Stock Index Membership
See which indices include Vineet Laboratories stock.
Check VINEETLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Vineet Laboratories Market Events Screener - Corporate Actions
Get Vineet Laboratories corporate actions including splits, bonuses, and buybacks.
Check Vineet Laboratories stock events that may affect VINEETLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 9.41% | ||
| Annual General Meeting | NA | -0.33% | ||
| Annual General Meeting | NA | -3.45% | ||
| Dividend | ₹ 1.00 /share | 14.41% | ||
| 2025-12-23 | 2025-12-23 | Rights | 13:12 | 0.09% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -2.17% |
| 2025-10-23 | 2025-10-23 | Quarterly Result Announcement | NA | 2.46% |
| 2025-07-22 | 2025-07-22 | Quarterly Result Announcement | NA | -4.13% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -13.60% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.80% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 2.65% |
Vineet Laboratories Competitors Screener - Peer Comparison
Screen VINEETLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Vineet Laboratories Company Announcements - News Screener
Screen VINEETLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-08 | Announcement under Regulation 30 (LODR)-Raising of Funds | View |
| 2026-03-05 | Intimation Of International Securities Identification Number (ISIN) For The Rights Entitlements To Be Credited For The Purpose Of The Rights Issue | View |
| 2026-03-05 | Corporate Action-Intimation of Right issue | View |
| 2026-03-05 | The Record Date For The Proposed Rights Issue Is Tuesday December 23 2025. | View |
| 2026-03-05 | Announcement under Regulation 30 (LODR)-Raising of Funds | View |
| 2026-03-05 | Intimation Of Receipt Of In-Principle Approval From BSE And NSE For Rights Issue | View |
| 2026-03-04 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2026-03-03 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-12 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-09 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-06 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-03 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-27 | Prior Intimation Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-27 | Intimation Of Submission Of Draft Letter Of Offer For The Proposed Rights Issue | View |